Capital World Investors
FLXN

Capital World Investors’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Capital World Investors’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,823,000
Closed -$44.1M – 627
2020
Q4 		$44.1M Hold
3,823,000
– – 0.01% 423
2020
Q3 		$39.8M Hold
3,823,000
– – 0.01% 411
2020
Q2 		$50.3M Buy
3,823,000
+1,312,300
+52% +$13.6M 0.01% 364
2020
Q1 		$19.8M Hold
2,510,700
– – 0.01% 394
2019
Q4 		$52M Hold
2,510,700
– – 0.01% 351
2019
Q3 		$34.4M Hold
2,510,700
– – 0.01% 369
2019
Q2 		$30.9M Hold
2,510,700
– – 0.01% 393
2019
Q1 		$31.3M Buy
2,510,700
+158,000
+7% +$2.11M 0.01% 382
2018
Q4 		$26.6M Hold
2,352,700
– – 0.01% 400
2018
Q3 		$44M Sell
2,352,700
-519,300
-18% -$11.9M 0.01% 389
2018
Q2 		$74.2M Hold
2,872,000
– – 0.02% 328
2018
Q1 		$64.4M Hold
2,872,000
– – 0.01% 341
2017
Q4 		$71.9M Buy
2,872,000
+334,000
+13% +$8.18M 0.02% 317
2017
Q3 		$61.4M Hold
2,538,000
– – 0.01% 339
2017
Q2 		$51.3M Buy
2,538,000
+49,000
+2% +$1.02M 0.01% 351
2017
Q1 		$67M Buy
2,489,000
+56,000
+2% +$1.14M 0.02% 327
2016
Q4 		$46.3M Buy
2,433,000
+709,949
+41% +$13.6M 0.01% 350
2016
Q3 		$33.7M Hold
1,723,051
– – 0.01% 369
2016
Q2 		$25.8M Hold
1,723,051
– – 0.01% 379
2016
Q1 		$15.9M Buy
1,723,051
+19,857
+1% +$241K ﹤0.01% 420
2015
Q4 		$32.8M Hold
1,703,194
– – 0.01% 382
2015
Q3 		$25.3M Buy
1,703,194
+245,748
+17% +$5.76M 0.01% 402
2015
Q2 		$31.9M Buy
1,457,446
+38,194
+3% +$770K 0.01% 401
2015
Q1 		$32M Hold
1,419,252
– – 0.01% 404
2014
Q4 		$28.7M Buy
1,419,252
+440,000
+45% +$7.97M 0.01% 416
2014
Q3 		$17.9M Buy
979,252
+229,252
+31% +$3.32M 0.01% 442
2014
Q2 		$10.1M Buy
750,000
+27,800
+4% +$379K ﹤0.01% 478
2014
Q1 		$11.9M Buy
+722,200
New +$12.5M ﹤0.01% 459

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CC
Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Capital World Investors's FLXN Position: Q1 2021 in Review

Capital World Investors sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2021, closing a stake of 3,823,000 shares — an estimated $44.1M sold.

Capital World Investors first reported a position in FLXN in Q1 2014 and held it in 28 quarters. The position peaked at $74.2M in Q2 2018. 145 funds tracked by Wall St. Rank hold FLXN as of Q1 2021.

  • Capital World Investors reported no remaining Flexion Therapeutics, Inc. position as of Q1 2021 after selling out during the quarter.
  • Capital World Investors sold 3,823,000 Flexion Therapeutics, Inc. shares in Q1 2021, an estimated $44.1M.
  • Capital World Investors first reported a position in Flexion Therapeutics, Inc. in Q1 2014 and held it in 28 quarters.
  • Capital World Investors's Flexion Therapeutics, Inc. position peaked at $74.2M in Q2 2018.
  • 145 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2021.

Based on Capital World Investors's 13F filing for Q1 2021, filed 14 May 2021.